Skip to main content
NCBI home page
Protein & Cell logoLink to Protein & Cell
. 2012 Aug 4;3(9):701–713. doi: 10.1007/s13238-012-2049-y

Cell type specificity of signaling: view from membrane receptors distribution and their downstream transduction networks

Ying He 1,2,3, Zhonghao Yu 4, Dongya Ge 1,3,5, Rui Wang-Sattler 4, Hans-Jürgen Thiesen 6, Lu Xie 2,✉, Yixue Li 1,2,✉
PMCID: PMC4875372  PMID: 22802048

Abstract

Studies on cell signaling pay more attention to spatial dynamics and how such diverse organization can relate to high order of cellular capabilities. To overview the specificity of cell signaling, we integrated human receptome data with proteome spatial expression profiles to systematically investigate the specificity of receptors and receptor-triggered transduction networks across 62 normal cell types and 14 cancer types. Six percent receptors showed cell-type-specific expression, and 4% signaling networks presented enriched cell-specific proteins induced by the receptors. We introduced a concept of “response context” to annotate the cell-type dependent signaling networks. We found that most cells respond similarly to the same stimulus, as the “response contexts” presented high functional similarity. Despite this, the subtle spatial diversity can be observed from the difference in network architectures. The architecture of the signaling networks in nerve cells displayed less completeness than that in glandular cells, which indicated cellular-context dependent signaling patterns are elaborately spatially organized. Likewise, in cancer cells most signaling networks were generally dysfunctional and less complete than that in normal cells. However, glioma emerged hyper-activated transduction mechanism in malignant state. Receptor ATP6AP2 and TNFRSF21 induced rennin-angiotensin and apoptosis signaling were found likely to explain the glioma-specific mechanism. This work represents an effort to decipher context-specific signaling network from spatial dimension. Our results indicated that although a majority of cells engage general signaling response with subtle differences, the spatial dynamics of cell signaling can not only deepen our insights into different signaling mechanisms, but also help understand cell signaling in disease.

Electronic Supplementary Material

The online version of this article (doi:10.1007/s13238-012-2049-y contains supplementary material, which is available to authorized users.

Keywords: plasma membrane receptor, cellular signaling transduction network, diversity, cell type specific, spatial expression profile

Electronic Supplementary Material

Supplementry Material (PDF 133 kb) (132.3KB, pdf)

Footnotes

These authors contributed equally to the work.

Electronic Supplementary Material

The online version of this article (doi:10.1007/s13238-012-2049-y contains supplementary material, which is available to authorized users.

Contributor Information

Lu Xie, Email: xielu@scbit.org.

Yixue Li, Email: yxli@sibs.ac.cn.

References

  1. Ager E.I., Neo J., Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis. 2008;29:1675–1684. doi: 10.1093/carcin/bgn171. [DOI] [PubMed] [Google Scholar]
  2. Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J.D. General principles of cell signaling. Molecular biology of the cell. New York: Garland Science; 1994. [Google Scholar]
  3. Alexa A., Rahnenführer J., Lengauer T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics. 2006;22:1600–1607. doi: 10.1093/bioinformatics/btl140. [DOI] [PubMed] [Google Scholar]
  4. Arrieta O., Guevara P., Escobar E., García-Navarrete R., Pineda B., Sotelo J. Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br J Cancer. 2005;92:1247–1252. doi: 10.1038/sj.bjc.6602483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Asai N., Jijiwa M., Enomoto A., Kawai K., Maeda K., Ichiahara M., Murakumo Y., Takahashi M. RET receptor signaling: Dysfunction in thyroid cancer and Hirschsprung’s disease. Pathol Int. 2006;56:164–172. doi: 10.1111/j.1440-1827.2006.01942.x. [DOI] [PubMed] [Google Scholar]
  6. Bache K.G., Slagsvold T., Stenmark H. Defective downregulation of receptor tyrosine kinases in cancer. EMBO J. 2004;23:2707–2712. doi: 10.1038/sj.emboj.7600292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ben-Shlomo I., Yu Hsu S., Rauch R., Kowalski H.W., Hsueh A.J.W. Signaling receptome: a genomic and evolutionary perspective of plasma membrane receptors involved in signal transduction. Sci STKE. 2003;2003:re9. doi: 10.1126/stke.2003.187.re9. [DOI] [PubMed] [Google Scholar]
  8. Berardini T.Z., Khodiyar V.K., Lovering R.C., Talmud P. The Gene Ontology in 2010: extensions and refinements. Nucleic Acids Res. 2010;38:D331–D335. doi: 10.1093/nar/gkp1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature. 2001;411:355–365. doi: 10.1038/35077225. [DOI] [PubMed] [Google Scholar]
  10. Bouralexis S., Findlay D.M., Evdokiou A. Death to the bad guys: targeting cancer via Apo2L/TRAIL. Apoptosis. 2005;10:35–51. doi: 10.1007/s10495-005-6060-0. [DOI] [PubMed] [Google Scholar]
  11. van Boxel-Dezaire A.H., Rani M.R., Stark G.R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity. 2006;25:361–372. doi: 10.1016/j.immuni.2006.08.014. [DOI] [PubMed] [Google Scholar]
  12. Brakebusch C., Grose R., Quondamatteo F., Ramirez A., Jorcano J.L., Pirro A., Svensson M., Herken R., Sasaki T., Timpl R., et al. Skin and hair follicle integrity is crucially dependent on [beta]1 integrin expression on keratinocytes. EMBO J. 2000;19:3990–4003. doi: 10.1093/emboj/19.15.3990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Burnier M. Angiotensin II type 1 receptor blockers. Circulation. 2001;103:904–912. doi: 10.1161/01.CIR.103.6.904. [DOI] [PubMed] [Google Scholar]
  14. Cirulli V., Yebra M. Netrins: beyond the brain. Nat Rev Mol Cell Biol. 2007;8:296–306. doi: 10.1038/nrm2142. [DOI] [PubMed] [Google Scholar]
  15. Clozel M., Breu V., Gray G.A., Kalina B., Löffler B.M., Burri K., Cassal J.M., Hirth G., Müller M., Neidhart W. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol. Exp. Ther. 1994;270:228–235. [PubMed] [Google Scholar]
  16. Culotti J.G., Merz D.C. DCC and netrins. Curr Opin Cell Biol. 1998;10:609–613. doi: 10.1016/S0955-0674(98)80036-7. [DOI] [PubMed] [Google Scholar]
  17. Cui J., Mao X., Olman V., Hastings P.J., Xu Y. Hypoxia and miscoupling between reduced energy efficiency and signaling to cell proliferation drive cancer to grow increasingly faster. J Mol Cell Biol. 2012;4:174–176. doi: 10.1093/jmcb/mjs017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Davenport, A.P., D’Orléans-Juste, P., Godfraind, T., Maguire, J.J., Ohlstein, E.H., and Ruffolo, R.R. (2008). Endothelin receptors introductory chapter IUPHAR database.
  19. Dikic I., Giordano S. Negative receptor signalling. Curr Opin Cell Biol. 2003;15:128–135. doi: 10.1016/S0955-0674(03)00004-8. [DOI] [PubMed] [Google Scholar]
  20. Dong S., Allen J.A., Farrell M., Roth B.L. A chemicalgenetic approach for precise spatio-temporal control of cellular signaling. Mol Biosyst. 2010;6:1376–1380. doi: 10.1039/c002568m. [DOI] [PubMed] [Google Scholar]
  21. Fennell D.A., Rudd R.M. Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development. Lancet Oncol. 2004;5:354–362. doi: 10.1016/S1470-2045(04)01492-5. [DOI] [PubMed] [Google Scholar]
  22. De Ferrari G.V., Inestrosa N.C. Wnt signaling function in Alzheimer’s disease. Brain Res. Brain Res Rev. 2000;33:1–12. doi: 10.1016/S0165-0173(00)00021-7. [DOI] [PubMed] [Google Scholar]
  23. Fischer O.M., Hart S., Gschwind A., Ullrich A. EGFR signal transactivation in cancer cells. Biochem Soc Trans. 2003;31:1203–1208. doi: 10.1042/bst0311203. [DOI] [PubMed] [Google Scholar]
  24. Furutani K., Aihara T., Nakamura E., Tanaka S., Ichikawa A., Ohtsu H., Okabe S. Crucial role of histamine for regulation of gastric acid secretion ascertained by histidine decarboxylaseknockout mice. J Pharmacol Exp Ther. 2003;307:331–338. doi: 10.1124/jpet.103.052019. [DOI] [PubMed] [Google Scholar]
  25. Höcker M., Zhang Z., Koh T.J., Wang T.C. The regulation of histidine decarboxylase gene expression. Yale J Biol Med. 1996;69:21–33. [PMC free article] [PubMed] [Google Scholar]
  26. Houslay M.D., Kolch W. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol. 2000;58:659–668. [PubMed] [Google Scholar]
  27. Hsueh R.C., Natarajan M., Fraser I., Pond B., Liu J., Mumby S., Han H., Jiang L.I., Simon M.I., Taussig R., et al. Deciphering signaling outcomes from a system of complex networks. Sci Signal. 2009;2:ra22. doi: 10.1126/scisignal.2000054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jacox E., Gotea V., Ovcharenko I., Elnitski L. Tissuespecific and ubiquitous expression patterns from alternative promoters of human genes. PLoS ONE. 2010;5:e12274. doi: 10.1371/journal.pone.0012274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jensen L.J., Kuhn M., Stark M., Chaffron S., Creevey C., Muller J., Doerks T., Julien P., Roth A., Simonovic M., et al. STRING 8—a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2009;37:D412–416. doi: 10.1093/nar/gkn760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Jordan J.D., Landau E.M., Iyengar R. Signaling networks: the origins review of cellular multitasking. Cell. 2000;103:193–200. doi: 10.1016/S0092-8674(00)00112-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003;46:3–19. doi: 10.1007/s00125-003-1190-9. [DOI] [PubMed] [Google Scholar]
  32. Kanehisa M., Goto S., Furumichi M., Tanabe M., Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010;38:D355–360. doi: 10.1093/nar/gkp896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kholodenko B.N. Cell signalling dynamics in time and space. Nat Rev Mol Cell Biol. 2006;7:165–176. doi: 10.1038/nrm1838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Kiel C., Serrano L. Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signaling. Sci Signal. 2009;2:ra38. doi: 10.1126/scisignal.2000397. [DOI] [PubMed] [Google Scholar]
  35. Larrivée B., Freitas C., Trombe M., Lv X., Delafarge B., Yuan L., Bouvrée K., Bréant C., Del Toro R., Bréchot N., et al. Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis. Genes Dev. 2007;21:2433–2447. doi: 10.1101/gad.437807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lehrer S. Glioblastoma and dementia may share a common cause. Med Hypotheses. 2010;75:67–68. doi: 10.1016/j.mehy.2010.01.031. [DOI] [PubMed] [Google Scholar]
  37. Lin W., Liu W., Hwang M. Topological and organizational properties of the products of house-keeping and tissuespecific genes in protein-protein interaction networks. BMC Syst Biol. 2009;3:32. doi: 10.1186/1752-0509-3-32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Lu X., Le Noble F., Yuan L., Jiang Q., De Lafarge B., Sugiyama D., Bréant C., Claes F., De Smet F., Thomas J.-L., et al. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature. 2004;432:179–186. doi: 10.1038/nature03080. [DOI] [PubMed] [Google Scholar]
  39. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol. 2000;1:120–130. doi: 10.1038/35040009. [DOI] [PubMed] [Google Scholar]
  40. Maxwell J.A., Johnson S.P., Quinn J.A., McLendon R.E., Ali-Osman F., Friedman A.H., Herndon J.E., Bierau K., Bigley J., Bigner D.D., et al. Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma. Mol Cancer Ther. 2006;5:2531–2539. doi: 10.1158/1535-7163.MCT-06-0106. [DOI] [PubMed] [Google Scholar]
  41. Miller-Jensen K., Janes K.A., Brugge J.S., Lauffenburger D.A. Common effector processing mediates cell-specific responses to stimuli. Nature. 2007;448:604–608. doi: 10.1038/nature06001. [DOI] [PubMed] [Google Scholar]
  42. Nguyen G. Renin, (pro)renin and receptor: an update. Clin Sci. 2011;120:169–178. doi: 10.1042/CS20100432. [DOI] [PubMed] [Google Scholar]
  43. Overington J.P., Al-Lazikani B., Hopkins A.L. How many drug targets are there? Nat Rev Drug Discov. 2006;5:993–996. doi: 10.1038/nrd2199. [DOI] [PubMed] [Google Scholar]
  44. Ramey G., Deschemin J.-C., Durel B., Canonne-Hergaux F., Nicolas G., Vaulont S. Hepcidin targets ferroportin for degradation in hepatocytes. Haematologica. 2010;95:501–504. doi: 10.3324/haematol.2009.014399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Round J., Stein E. Netrin signaling leading to directed growth cone steering. Curr Opin Neurobiol. 2007;17:15–21. doi: 10.1016/j.conb.2007.01.003. [DOI] [PubMed] [Google Scholar]
  46. Schug J., Schuller W.P., Kappen C., Salbaum J.M., Bucan M., Stoeckert C. Promoter features related to tissue specificity as measured by Shannon entropy. Genome Biol. 2005;6:R33. doi: 10.1186/gb-2005-6-4-r33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sharman J.L., Mpamhanga C.P., Spedding M., Germain P., Staels B., Dacquet C., Laudet V., Harmar A.J., NC-IUPHAR IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data. Nucleic Acids Res. 2010;39:D534–D538. doi: 10.1093/nar/gkq1062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sibley D.R., Benovic J.L., Caron M.G., Lefkowitz R.J. Phosphorylation of cell surface receptors: a mechanism for regulating signal transduction pathways. Endocr Rev. 1988;9:38–56. doi: 10.1210/edrv-9-1-38. [DOI] [PubMed] [Google Scholar]
  49. Silverthorn D.U., Ober W.C. Human physiology: an integrated approach. San Francisco: Pearson/Benjamin Cummings; 2007. [Google Scholar]
  50. Tanaka S., Hamada K., Yamada N., Sugita Y., Tonai S., Hunyady B., Palkovits M., Falus A., Watanabe T., Okabe S., et al. Gastric acid secretion in L-histidine decarboxylase-deficient mice. Gastroenterology. 2002;122:145–155. doi: 10.1053/gast.2002.30312. [DOI] [PubMed] [Google Scholar]
  51. Uhlen M., Oksvold P., Fagerberg L., Lundberg E., Jonasson K., Forsberg M., Zwahlen M., Kampf C., Wester K., Hober S., et al. Towards a knowledge-based Human Protein Atlas. Nat Biotech. 2010;28:1248–1250. doi: 10.1038/nbt1210-1248. [DOI] [PubMed] [Google Scholar]
  52. Vallone D., Picetti R., Borrelli E. Structure and function of dopamine receptors. Neurosci Biobehav Rev. 2000;24:125–132. doi: 10.1016/S0149-7634(99)00063-9. [DOI] [PubMed] [Google Scholar]
  53. Wang J.Z., Du Z., Payattakool R., Yu P.S., Chen C.-F. A new method to measure the semantic similarity of GO terms. Bioinformatics. 2007;23:1274–1281. doi: 10.1093/bioinformatics/btm087. [DOI] [PubMed] [Google Scholar]
  54. Wilkes M.C., Repellin C.E., Hong M., Bracamonte M., Penheiter S.G., Borg J.-P., Leof E.B. Erbin and the NF2 tumor suppressor merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-β. Dev Cell. 2009;16:433–444. doi: 10.1016/j.devcel.2009.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Won J.K., Yang H.W., Shin S.Y., Lee J.H., Heo W.D., Cho K.H. The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor. J Mol Cell Biol. 2012;4:153–163. doi: 10.1093/jmcb/mjs021. [DOI] [PubMed] [Google Scholar]
  56. Yu G., Li F., Qin Y., Bo X., Wu Y., Wang S. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics. 2010;26:976–978. doi: 10.1093/bioinformatics/btq064. [DOI] [PubMed] [Google Scholar]
  57. Zahnow C.A., Yi H.F., McBride O.W., Joseph D.R. Cloning of the cDNA encoding human histidine decarboxylase from an erythroleukemia cell line and mapping of the gene locus to chromosome 15. DNA Seq. 1991;1:395–400. doi: 10.3109/10425179109020795. [DOI] [PubMed] [Google Scholar]
  58. Zhang X.P., Kamata T., Yokoyama K., Puzon-McLaughlin W., Takada Y. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (Metargidin, ADAM-15) with Integrin αvβ3. J Biol Chem. 1998;273:7345–7350. doi: 10.1074/jbc.273.13.7345. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementry Material (PDF 133 kb) (132.3KB, pdf)

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES